Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
John A. Quinlan
Observed names:
John Andrew Quinlan,
John Quinlan,
Quinlan, John Andrew
Institution:
University of Maryland, College Park
Observed institutions:
National Institutes of Health,
National Cancer Institute,
Center for Cancer Research,
University of Maryland, College Park
ORCID:
0000-0002-8547-1535
Observed ORCID:
0000-0002-8547-1535
OpenAlex ID:
A5103210165
Carrier‐Free, Amorphous Verteporfin Nanodrug for Enhanced Photodynamic Cancer Therapy and Brain Drug Delivery
2024
·
John A. Quinlan
, Collin T. Inglut
, et al.
·
Advanced Science
·
44
Self‐Assembled Verteporfin Nanoparticles for Photodynamic and Light‐Independent Therapy in Glioblastoma
2024
·
John A. Quinlan
, Kaylin Baumiller
, et al.
·
Advanced NanoBiomed Research
·
9
Light‐activatable minimally invasive ethyl cellulose ethanol ablation: Biodistribution and potential applications
2024
·
Jeffrey Yang
, Chen‐Hua Ma
, et al.
·
Bioengineering & Translational Medicine
·
9
Synergizing photodynamic therapy and ethanol ablation: Light‐activatable sustained‐exposure ethanol injection technology for enhanced tumor ablation
2025
·
Chen‐Hua Ma
, Jeffrey Yang
, et al.
·
Bioengineering & Translational Medicine
·
5
Identification of NanoLuciferase Substrates Transported by Human ABCB1 and ABCG2 and Their Zebrafish Homologs at the Blood-Brain Barrier
2024
·
John A. Quinlan
, Sashank Sabbineni
, et al.
·
Molecular Pharmacology
·
3
PDF
Transmission Electron Microscopy Study of a Nanosuspension of Verteporfin and Evaluation of Stability in Human Serum
2024
·
John Quinlan
, Wen-An Chiou
, et al.
·
Microscopy and Microanalysis
·
2
Characterization of testosterone-loaded polydimethylsiloxane pellets for a mouse model of metastatic prostate cancer
2019
·
John Andrew Quinlan
, Alessandro Fatatis
·
iDEA - Drexel University Institutional Repository
Show more works
View as search
Works count:
12
Citation count:
72
H-index:
4
I10-index:
1
Year
Topic
Type